Sohel H, Kiyono T, Zahan U, Razia S, Ishikawa M, Yamashita H
Int J Mol Sci. 2025; 26(5).
PMID: 40076621
PMC: 11901000.
DOI: 10.3390/ijms26051995.
Gugu Nkosi P, Chandran R, Abrahamse H
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024; 16(6):e1997.
PMID: 39568119
PMC: 11579242.
DOI: 10.1002/wnan.1997.
Faupel-Badger J, Kohaar I, Bahl M, Chan A, Campbell J, Ding L
Nat Rev Cancer. 2024; 24(11):792-809.
PMID: 39354069
DOI: 10.1038/s41568-024-00744-0.
Holder A, Dedeilia A, Sierra-Davidson K, Cohen S, Liu D, Parikh A
Nat Rev Cancer. 2024; 24(7):498-512.
PMID: 38867074
DOI: 10.1038/s41568-024-00705-7.
Zhang N, Ma F, Guo D, Pang Y, Wang C, Zhang Y
PLoS Comput Biol. 2024; 20(4):e1012068.
PMID: 38683860
PMC: 11081510.
DOI: 10.1371/journal.pcbi.1012068.
Latest Progress in Risk-Adapted Surgery for Medullary Thyroid Cancer.
Machens A, Lorenz K, Brandenburg T, Fuhrer D, Weber F, Dralle H
Cancers (Basel). 2024; 16(5).
PMID: 38473279
PMC: 10930958.
DOI: 10.3390/cancers16050917.
Integrating Artificial Intelligence for Advancing Multiple-Cancer Early Detection via Serum Biomarkers: A Narrative Review.
Wang H, Lin W, Zhou C, Yang Z, Kalpana S, Lebowitz M
Cancers (Basel). 2024; 16(5).
PMID: 38473224
PMC: 10931531.
DOI: 10.3390/cancers16050862.
Chargaff's second parity rule lies at the origin of additive genetic interactions in quantitative traits to make omnigenic selection possible.
Matkarimov B, Saparbaev M
PeerJ. 2023; 11:e16671.
PMID: 38107580
PMC: 10725672.
DOI: 10.7717/peerj.16671.
Systems Biology Modeling of Cancer Nonlinear Dynamics.
Alameddine A
Methods Mol Biol. 2023; 2745:121-134.
PMID: 38060183
DOI: 10.1007/978-1-0716-3577-3_8.
Cancer Evolution: A Multifaceted Affair.
Ciriello G, Magnani L, Aitken S, Akkari L, Behjati S, Hanahan D
Cancer Discov. 2023; 14(1):36-48.
PMID: 38047596
PMC: 10784746.
DOI: 10.1158/2159-8290.CD-23-0530.
A Nexus between Genetic and Non-Genetic Mechanisms Guides KRAS Inhibitor Resistance in Lung Cancer.
Kulkarni P, Mohanty A, Ramisetty S, Duvivier H, Khan A, Shrestha S
Biomolecules. 2023; 13(11).
PMID: 38002269
PMC: 10668935.
DOI: 10.3390/biom13111587.
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors.
Marques Da Costa M, Zaidi S, Scoazec J, Droit R, Lim W, Marchais A
Commun Biol. 2023; 6(1):949.
PMID: 37723198
PMC: 10507044.
DOI: 10.1038/s42003-023-05320-0.
TERRA beyond cancer: the biology of telomeric repeat-containing RNAs in somatic and germ cells.
Rivosecchi J, Cusanelli E
Front Aging. 2023; 4:1224225.
PMID: 37636218
PMC: 10448526.
DOI: 10.3389/fragi.2023.1224225.
Challenges and Opportunities in Developing Targeted Therapies for Triple Negative Breast Cancer.
Chapdelaine A, Sun G
Biomolecules. 2023; 13(8).
PMID: 37627272
PMC: 10452226.
DOI: 10.3390/biom13081207.
A novel tumor 4-driver gene signature for the prognosis of hepatocellular carcinoma.
Guo H, Lu F, Lu R, Huang M, Li X, Yuan J
Heliyon. 2023; 9(6):e17054.
PMID: 37484410
PMC: 10361245.
DOI: 10.1016/j.heliyon.2023.e17054.
Inhibition of Cancer Development by Natural Plant Polyphenols: Molecular Mechanisms.
Lyubitelev A, Studitsky V
Int J Mol Sci. 2023; 24(13).
PMID: 37445850
PMC: 10341686.
DOI: 10.3390/ijms241310663.
Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort.
Tredan O, Toulmonde M, Le Tourneau C, Montane L, Italiano A, Ray-Coquard I
Cancers (Basel). 2023; 15(13).
PMID: 37444551
PMC: 10340237.
DOI: 10.3390/cancers15133441.
Dietary Oncopharmacognosy as a Crosswalk between Precision Oncology and Precision Nutrition.
Thompson H, Lutsiv T, McGinley J, Hussan H, Playdon M
Nutrients. 2023; 15(9).
PMID: 37432381
PMC: 10180692.
DOI: 10.3390/nu15092219.
You complete me: tumor cell-myeloid cell nuclear fusion as a facilitator of organ-specific metastasis.
Cozzo A, Coleman M, Hursting S
Front Oncol. 2023; 13:1191332.
PMID: 37427108
PMC: 10324515.
DOI: 10.3389/fonc.2023.1191332.
Genotoxicity assessment: opportunities, challenges and perspectives for quantitative evaluations of dose-response data.
Menz J, Gotz M, Gundel U, Gurtler R, Herrmann K, Hessel-Pras S
Arch Toxicol. 2023; 97(9):2303-2328.
PMID: 37402810
PMC: 10404208.
DOI: 10.1007/s00204-023-03553-w.